Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variceal bleeding: pharmacological therapy.

Jaime Bosch1, Juan G Abraldes

  • 1Hepatic Hemodynamics Laboratory, Liver Unit, IMD, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain. jbosch@clinic.ub.es

Digestive Diseases (Basel, Switzerland)
|May 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inconsistent Strategies to Mitigate the Effects of Batrachochytrium salamandrivorans, Europe.

Emerging infectious diseases·2026
Same author

Estimating the velocity and direction of African Swine Fever spread in wild boar populations in South Korea using Trend-Surface Analysis.

PloS one·2026
Same author

Fungal Panzootic Increasingly Threatens Temperate Amphibian Species While Impact Has Stabilised in Equatorial Regions.

Global change biology·2026
Same author

Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.

British journal of clinical pharmacology·2025
Same author

Risk Mapping of African Swine Fever in Domestic Pigs and Wild Boars to Enhance Management and Surveillance in Asia.

Transboundary and emerging diseases·2025
Same author

A novel amphibian herpesvirus (candidate Batravirus ranidallo5) associated with disease in free-ranging Iberian painted frogs (Discoglossus galganoi) in Spain.

Scientific reports·2025
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Lowering hepatic venous pressure gradient below 12 mm Hg prevents portal hypertension complications. A 20% reduction in portal pressure also protects against variceal bleeding, guiding drug therapy choices.

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Pharmacology

Background:

  • Portal hypertension complications are preventable by managing hepatic venous pressure gradient (HVPG).
  • Achieving HVPG below 12 mm Hg or a 20% baseline reduction is key for preventing variceal bleeding.

Purpose of the Study:

  • To establish the rationale for pharmacological interventions aimed at reducing portal pressure.
  • To outline drug therapy strategies for managing portal hypertension and its complications.

Main Methods:

  • Review of pharmacological approaches for portal pressure reduction.
  • Categorization of therapies into vasoconstrictors, vasodilators, and combination treatments.
  • Distinction between oral agents for long-term prevention and parenteral agents for acute treatment.

Related Experiment Videos

Main Results:

  • Pharmacological therapy targets portal pressure reduction through decreased inflow or hepatic resistance.
  • Oral beta-blockers and nitrates are indicated for long-term variceal bleeding prevention.
  • Parenteral somatostatin analogues and terlipressin are used for acute variceal bleeding management.

Conclusions:

  • Effective management of portal hypertension relies on achieving specific HVPG targets.
  • A combination of therapeutic strategies, including pharmacological agents, is essential for preventing and treating complications.
  • Drug selection depends on the clinical scenario, whether for long-term prevention or acute management.